Chwen-Yuen Angie Chen, MD, FACP
Private practice internist and addiction medicine specialist, Editor, California Society of Addiction Medicine News
Dr. Chen has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
In 2010, TCPR published an overview of Suboxone (buprenorphine/naloxone) (TCPR, May 2010). Lots has happened in the three years since then.
Director of Training and Education in Child and Adolescent Psychiatry, Mount Sinai St. Luke’s Hospital, New York, NY
Dr. Gaveras has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Prescription medication abuse is the among the biggest health issues facing the United States, but prescription medications have an important place in responsible medical treatment.
Lance Dodes, MD
Training and supervising analyst, Boston Psychoanalytic Society and Institute, Assistant clinical professor of psychiatry, Harvard Medical School
Dr. Dodes has disclosed that he receives royalties for books on addiction. Dr. Balt has reviewed this article and found no evidence of bias in this educational activity.
Expert and author Dr. Lance Dodes describes the psychological origins of addiction and how getting to the bottom of what drives an addict is the key to helping him or her quit for good.
Section editor, Glen Spielmans, PhDGlen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.
Nonpharmacological methods to treat depression include more than just ECT: recent developments include promising strategies like repetitive transcranial magnetic stimulation (rTMS) and vagal nerve stimulation (VNS). Another procedure, transcranial direct current stimulation (tDCS) involves the application of weak direct electrical current to the brain via scalp electrodes, which can be positioned to deliver currents that increase or decrease cortical excitability.
Douglas Tucker, MD
Affiliated faculty, Forensic psychiatry fellowship program, University of California, San Francisco
Dr. Tucker has disclosed that he has no relevant relationships or financial interests in any commercial companies pertaining to this educational activity.Mikel Matto, MD
Resident in psychiatry, University of California, San Francisco
Dr. Matto has disclosed that he has no relevant relationships or financial interests in any commercial companies pertaining to this educational activity.
In the aftermath of a tragic event carried out by an individual with a psychiatric history, descriptions of the perpetrator as being in some way “off” or “quiet” have almost become cliché. And those clichés, when we inevitably compare them to our own patients, make many of us nervous.
Josh Sonkiss, MD
Chief Resident University of Utah Department of Psychiatry
Dr. Sonkiss has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Dealing with potentially violent patients is daunting, but we can play an effective role in assessing and reducing violence risk. In this article I’ll discuss some practical techniques to help you accomplish this in everyday practice.
Annette Hanson, MD
Clinical assistant professor, Director, fellowship in forensic psychiatry, University of Maryland School of Medicine
Dr. Hanson has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
The legal system can provide much-needed help to psychiatry patients and their families. Forensic psychiatrist Annette Hanson, MD, expertly explains legal options such as mental health courts and guardianship.
We have an abundance of medications to treat depression, but “treatment resistance” remains all too common. Accordingly, there has been a rise in the number of “augmentation” or “adjunctive” medications to address this population.